Your browser doesn't support javascript.
loading
Immunogenicity of heterologous recombinant adenovirus prime-boost vaccine regimens is enhanced by circumventing vector cross-reactivity.
Thorner, Anna R; Lemckert, Angelique A C; Goudsmit, Jaap; Lynch, Diana M; Ewald, Bonnie A; Denholtz, Matthew; Havenga, Menzo J E; Barouch, Dan H.
Affiliation
  • Thorner AR; Research East Room 213, Division of Viral Pathogenesis, Beth Israel Deaconess Medical Center, 330 Brookline Avenue, Boston, MA 02215, USA.
J Virol ; 80(24): 12009-16, 2006 Dec.
Article in En | MEDLINE | ID: mdl-17035318
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Vaccines, Synthetic / Adenoviridae / Cross Reactions / Genetic Vectors Type of study: Risk_factors_studies Limits: Animals Language: En Journal: J Virol Year: 2006 Document type: Article Affiliation country: United States Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Vaccines, Synthetic / Adenoviridae / Cross Reactions / Genetic Vectors Type of study: Risk_factors_studies Limits: Animals Language: En Journal: J Virol Year: 2006 Document type: Article Affiliation country: United States Country of publication: United States